ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "genetics"

  • Abstract Number: 2060 • ACR Convergence 2022

    Increased Risk of Adverse Renal Outcomes in Patients of African Ancestry with Systemic Lupus Erythematosus (SLE) – Role of APOL1

    Gul Karakoc, Ge Liu, Jorge Gamboa, Cecilia Chung, Jonathan Mosley, Michael Stein and Vivian Kawai, Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: SLE disproportionately affects individuals of African (AA) compared to European ancestry (EA). In addition to a higher incidence, the disease is more severe in…
  • Abstract Number: 0137 • ACR Convergence 2022

    Polyarticular Arthritis and Osteolysis Caused by Mutations in the ASAH1 Gene: Farber Disease Clinical Presentations in the First-ever Natural History Study

    Alexander Solyom1, Kathleen Crosby2, Nils Confer2 and Jaime Lopez Valdez3, 1Aceragen, Basel, Switzerland, 2Aceragen, Durham, NC, 3Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico

    Background/Purpose: Farber disease is frequently misdiagnosed as polyarticular juvenile idiopathic arthritis or seronegative rheumatoid arthritis which leads to a delay in diagnosis for many patients.…
  • Abstract Number: 1120 • ACR Convergence 2022

    Transcriptome-Wide Association Study of Sjögren’s Disease Risk Alleles Identifies Novel Genes with Altered Expression in Minor Salivary Gland and Other Tissues

    Marcin Radziszewski1, Mandi Wiley1, Bhuwan Khatri1, Kandice Tessneer1, Astrid Rasmussen1, Professor Simon Bowman2, Lida Radfar3, Roald Omdal4, Marie Wahren-Herlenius5, Blake Warner6, Torsten Witte7, Roland Jonsson8, Maureen Rischmueller9, Patrick Gaffney1, Judith James1, Lars Ronnblom10, R. Hal Scofield3, Xavier Mariette11, Marta Alarcon-Riquelme12, Fai Ng13, Gunnel Nordmark10, Umesh Deshmukh1, A. Darise Farris1 and Christopher Lessard1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University Hospitals Birmingham, Birmingham, United Kingdom, 3University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Stavanger University, Stavanger, Norway, 5Karolinska Institutet, Stockholm, Sweden, 6National Institutes of Health, Bethesda, MD, 7MH-Hannover, Hannover, Germany, 8University of Bergen, Bergen, Norway, 9RheumatologySA, Adelaide, Australia, 10Uppsala University, Uppsala, Sweden, 11Paris-Saclay University, Rueil Malmaison, Ile-de-France, France, 12Center for Genomics and Oncological Research (GENYO), Granada, Spain, 13Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

    Background/Purpose: Sjögren's disease (SjD) is an autoimmune disease characterized by reduced function of exocrine glands, but also has systemic manifestations affecting multiple organs, including abnormal…
  • Abstract Number: 1538 • ACR Convergence 2022

    Decreased Prevalence of Autoimmune Connective Tissue Diseases in Type 1 and Type 2 Diabetes

    Aya abugharbyeh, Sadik Khuder and bashar Kahaleh, University of Toledo, Toledo, OH

    Background/Purpose: Evidence suggest that autoimmune diseases tend to coexist at a higher rate than expected, reflecting a common pathogenetic pathway. However, data sets have shown…
  • Abstract Number: 2177 • ACR Convergence 2022

    Familial Clustering of Systemic Sclerosis, Autoimmunity, and Cancer History

    Mariana Bombini1, Nailú Sinicato1, Jacqueline Paredes2, Theresa Wampler Muskardin2, Tiago Nardi Amaral1, Ana Paula Del Rio1, Joao Marques Neto3, Timothy Niewold2 and Simone Appenzeller4, 1State University of Campinas, Campinas, São Paulo, Brazil, 2Hospital for Special Surgery, New York, NY, 3State University of Campinas, São Paulo, Brazil, 4Unicamp, Campinas, São Paulo, Brazil

    Background/Purpose: Systemic sclerosis (SSc) is a complex disease characterized by chronic inflammation, fibrosis, and vasculopathy. Genetic factors contribute to pathogenesis, but because it is a…
  • Abstract Number: 0149 • ACR Convergence 2022

    Autoinflammatory Diseases Associated with NOD2 and Other Concurrent Genetic Mutations

    Hafsa Nomani, Brianne Navetta-Modrov, Mark Yun and QingPing Yao, Stony Brook University, Stony Brook, NY

    Background/Purpose: Systemic autoinflammatoy diseases (SAIDs) are primarily caused by abnormal innate immune response. NOD-like receptors (NLRs) are intracellular sensors to the immune process, including NOD2,…
  • Abstract Number: 1121 • ACR Convergence 2022

    Intricate Roles of Low Gene Copy Numbers for Complement C4, C4A Deficiency and HLA-DRB1*03 as Genetic Risk Factors for Myositis, Its Subgroups and Autoantibodies

    Danlei Zhou1, Emily H King1, Simon Rothwell2, Olga Kryštůfková3, Antonella Notarnicola4, Samantha Coss1, Rabheh Abdul Aziz5, Katherine E Miller1, Amanda Dang1, G. Richard Yu1, Joanne Drew6, Emeli Lundstrom4, Lauren Pachman7, Gulnara Mamyrova8, Rodolfo V Curiel8, Boel De Paepe9, Jan De Bleecker9, Antony Payton10, William Ollier11, Terrance P O'Hanlon12, Ira Targoff12, Willy Flegel12, Vidya Sivaraman6, Edward Oberle6, Shoghik Akoghlanian6, Kyla Driest6, Charles H Spencer13, Yee Ling Wu14, Haikady N Nagaraja15, Stacy P Ardoin6, Hector Chinoy16, Lisa G Rider12, Frederick Miller12, Ingrid Lundberg17, Leonid Padyukov18, Jiří Vencovský3, Janine A Lamb2 and Chack-Yung Yu1, 1Center for Microbial Pathogenesis, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, OH, 2National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, The University of Manchester, Manchester, United Kingdom, 3Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 4Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 5Division of Rheumatology, Nationwide Children’s Hospital and Department of Pediatrics, The Ohio State University, Columbus, OH, 6Division of Rheumatology, Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University, Columbus, OH, 7Northwestern's Feinberg School of Medicine. Ann and Robert H. Lurie Children's Hospital of Chicago; Stanley Manne Children's Research Institute of Chicago, Lake Forest, IL, 8Division of Rheumatology, Department of Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, 9Department of Neurology, Ghent University Hospital, Ghent, Belgium, 10Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, 11Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, United Kingdom, 12Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, Bethesda, MD, 13Division of Rheumatology, Nationwide Children’s Hospital and Department of Pediatrics, The Ohio State University, Columbus, MS, 14Department of Microbiology and Immunology, Loyola University Chicago, Maywood, IL, 15Division of Biostatistics, The Ohio State University, Columbus, OH, 16The University of Manchester, Sale, United Kingdom, 17Karolinska Universitetssjukhuset, Karolinska Institutet, Stockholm, Sweden, 18Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are a group of autoimmune diseases characterized by autoantibodies plus infiltration of leukocytes into muscles and/or the skin, leading to…
  • Abstract Number: 1552 • ACR Convergence 2022

    Rare Variant Analysis of Aortopathy Genes in Takayasu’s Arteritis

    Hugh Alessi1, Yiming Luo1, Kaitlin Quinn2 and Peter Grayson3, 1NIH, Bethesda, MD, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 3National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD

    Background/Purpose: A set of genes has been associated with aortopathies, which are defined as non-inflammatory diseases where the integrity of large arteries is compromised leading…
  • Abstract Number: 2230 • ACR Convergence 2022

    Ultra-Rare Genetic Variation in Relapsing Polychondritis: A Whole-Exome Sequencing Study

    Yiming Luo1, Marcela Ferrada1, Keith Sikora2, Daniel Kastner3, Zuoming Deng4, Mengqi Zhang5, Hugh Alessi1, Virginia Kraus6, Andrew Allen6 and Peter Grayson7, 1National Institutes of Health, Bethesda, MD, 2National Institutes of Health Clinical Center, Bethesda, MD, 3National Human Genome Research Institute, Bethesda, MD, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 5University of Pennsylvania, Philadelphia, PA, 6Duke University, Durham, NC, 7National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD

    Background/Purpose: Relapsing polychondritis (RP) is a rare rheumatic disease of unknown etiology characterized by inflammations of cartilaginous structures and other tissues, particularly the ears, nose,…
  • Abstract Number: 0336 • ACR Convergence 2022

    Machine Learning Approach for the Prediction of Lupus Nephritis Renal Flares Using Polygenic Risk Score and Electronic Health Record

    Yi-Ming Chen1, Tzu-Hung Hsiao1, Seng-Cho Chou2 and Chi-Wei Chung2, 1Taichung Veterans General Hospital, Taichung, Taiwan, 2Department of Information Management, National Taiwan University, Taipei, Taiwan

    Background/Purpose: Lupus nephritis (LN) flares are associated with risks of renal failure and mortality in patients with systemic lupus erythematous (SLE). It is critical to…
  • Abstract Number: 1122 • ACR Convergence 2022

    Short Peripheral Blood Leukocyte Telomere Length in Rheumatoid Arthritis – Interstitial Lung Disease

    Pierre-Antoine Juge1, Tracy Doyle2, Seoyeon Lee3, Avram Walts4, Anthony Esposito5, Sergio Poli de Frias6, Ritu R. Gill7, Hiroto Hatabu8, Mizuki Nishino8, Michael Weinblatt9, Nancy A. Shadick6, Kristen Demoruelle10, Ivan O. Rosas11, Benjamin granger12, Kevin D Deane13, Bruno Crestani14, Paul Wolters15, Philippe Dieude16 and Joyce Lee13, 1Rheumatology department, Bichat Hospital, Paris, France, 2Brigham and Women's Hospital, Boston, MA, 3Department of Medicine, University of California, San Francisco, CA, 4Department of medicine, National Jewish Hospital, Denver, CO, 5Brigham and Women's Hospital, Department of Medicine, Boston, MA, 6Department of Medicine, Brigham and Women's Hospital, Boston, MA, 7Beth Israel Deaconess Medical Center, Radiology Department, Boston, MA, 8Department of Radiology, Brigham and Women's Hospital, Boston, MA, 9Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 10Department of Medicine, University of Colorado, Denver, CO, 11Baylor College of Medicine, Houston, TX, 12Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, PEPITES, F75013, Paris, France, Paris, France, 13University of Colorado Denver Anschutz Medical Campus, Denver, CO, 14Hopital Bichat, Paris University, Paris, France, 15UCSF, SF, 16Université Paris Cité, Paris, France

    Background/Purpose: Shortened telomere lengths (TL) have been associated with interstitial lung disease (ILD), in particular idiopathic pulmonary fibrosis (IPF). Given the phenotypic overlap between IPF…
  • Abstract Number: 1569 • ACR Convergence 2022

    Lung Involvement in VEXAS Syndrome

    Marta Casal Moura1, Misbah Baqir1, Yasmeen Tandon2, Matthew J. Samec3, Kaaren K. Reichard4, Abhishek Mangaonkar5, Ronald S. Go5, Kenneth J. Warrington6, Mrinal Patnaik7, Matthew J. Koster6 and Jay H. Ryu1, 1Mayo Clinic, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Rochester, USA, Rochester, 2Mayo Clinic, Radiology, Rochester, USA, Rochester, 3Mayo Clinic, Division of Rheumatology, Department of Medicine, Rochester, USA, Rochester, 4Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, USA, Rochester, 5Mayo Clinic, Division of Hematology, Department of Medicine, Rochester, USA, Rochester, 6Mayo Clinic, ROCHESTER, MN, 7Mayo Clinic, Division of Hematology, Department of Medicine, Rochester, United States of America, Rochester

    Background/Purpose: Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is a recently identified disorder caused by somatic mutations in the UBA1 gene of myeloid cells.…
  • Abstract Number: 2250 • ACR Convergence 2022

    Genetic and Environmental Risk Factors in Rheumatoid Arthritis-Associated Interstitial Lung Disease

    Austin Wheeler1, Yangyuna Yang1, Joshua Baker2, Jill Poole1, Dana Ascherman3, Gail Kerr4, Andreas Reimold5, Gary Kunkel6, Grant Cannon7, Katherine Wysham8, Namrata Singh9, Deana Lazaro10, Paul Monach11, S. Louis Bridges, Jr.12, Ted Mikuls13 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Pennsylvania, Philadelphia, PA, 3University of Pittsburgh, Pittsburgh, PA, 4Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 5University of Texas Southwestern Medical Center, Dallas, TX, 6University of Utah, Salt Lake City, UT, 7Retired, Salt Lake City, UT, 8VA Puget Sound/University of Washington, Seattle, WA, 9University of Washington, Bellevue, WA, 10VA New York Harbor Healthcare system, Short Hills, NJ, 11VA Boston Healthcare System, Boston, MA, 12Hospital for Special Surgery, New York, NY, 13Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: RA-associated interstitial lung disease (RA-ILD) is an extra-articular manifestation of RA causing substantial morbidity and mortality. Genetic risk variants, such as the MUC5B rs35705950…
  • Abstract Number: 0340 • ACR Convergence 2022

    Birth Order Is a Risk Factor for Systemic Lupus Erythematosus

    Nicole Shammas1, Priya Ramani2, Christopher Aston3, Ana Quintero-Del-Rio4, Judith James5, John Harley6, Isaac Harley7 and Hal Scofield5, 1University of Colorado School of Medicine, Aurora, CO, 2Tampa Rheumatology, Tampa, FL, 3University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4OU Children's Hospital, Oklahoma City, OK, 5Oklahoma Medical Research Foundation, Oklahoma City, OK, 6US Department of Veterans Affairs Medical Center, Cincinnati, OH, 7University of Colorado Anschutz Medical Campus, Aurora, CO

    Background/Purpose: Birth order effects have been described in several immune and non-immune disease states. While some studies have found an increased risk of developing autoimmune…
  • Abstract Number: 1123 • ACR Convergence 2022

    Excess of Rare Deleterious Variants Within JAK-STAT Pathway – Related Genes in Patients with Rheumatoid Arthritis Associated Interstitial Lung Disease

    Pierre-Antoine Juge1, Steven Gazal2, Raphaël Borie3, Lidwine Wemeau4, Marie-Pierre Debray5, Sebastien Ottaviani6, Sylvain Marchand Adam7, Christophe Richez8, Hilario Nunes9, Pascal Richette10, Caroline Kannengiesser11, Jérome Avouac12, Jean Sibilia13, René-Marc Flipo14, Vincent Cottin15, Thierry Schaeverbeke16, Martin Soubrier17, Nathalie Saidenberg-Kermanac’h18, Dominique Valeyre19, Catherine Boileau11, Bruno Crestani20 and Philippe Dieude21, 1Rheumatology department, Bichat Hospital, Paris, France, 2University of Southern California, Los Angeles, CA, 3Pulmonology department, Bichat Hospital, Paris, France, 4Pulmonology department, Lille University hospital, Lille, France, 5Radiology department, Hôpital Bichat, Paris, France, 6Hopital Bichat-Claude Bernard, Paris, France, 7Pulmonology department, Tours University Hospital, Tours, France, 8Université de Bordeaux, Bordeaux, France, 9Pulmonology department, Hopital Avicenne, Bobigny, France, 10Department of Rheumatology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France, 11Genetic Department, Bichat hospital, Paris, France, 12Rheumatology Department, Cochin hospital, Paris, France, 13University Hospital of Strasbourg, Strasbourg, France, 14Hôpital Roger Salengro, Lille, France, 15Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, University of Lyon, INRAE, Lyon, France, 16FHU ACRONIM, University Hospital of Bordeaux, University of Bordeaux, Bordeaux, France, 17Gabriel-Montpied Hospital, Clermont-Ferrand, France, 18Rheumatology Department, Avicenne Hospital, Bobigny, France, 19Pulmonology department, Avicenne Hospital, Bobigny, France, 20Hopital Bichat, Paris University, Paris, France, 21Université Paris Cité, Paris, France

    Background/Purpose: Interstitial lung disease (ILD) is a leading cause of morbidity and mortality in patients with RA. To date, there are no specific treatments available…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 29
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology